PharmaCyte Biotech, Inc.
PMCB- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001157075
No open-market purchases or sales by PharmaCyte Biotech, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $586.2K in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in PharmaCyte Biotech, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 35
- +8 vs. Q1 2022
- Shares held
- 3.92M
- +116.8K (+3.1%) vs. Q1 2022
- Total value
- $8.79M
- +$44.0K (+0.5%) vs. Q1 2022
- New holders
- 9
- 10 more added
- Sold out
- 1
- 6 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PMCB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $586.2K |
| Q1 2026 | 36 | $643.2K |
| Q4 2025 | 30 | $712.0K |
| Q3 2025 | 25 | $419.9K |
| Q2 2025 | 25 | $632.1K |
| Q1 2025 | 26 | $709.9K |
| Q4 2024 | 23 | $934.3K |
| Q3 2024 | 29 | $1.58M |
| Q2 2024 | 32 | $2.02M |
| Q1 2024 | 33 | $2.32M |
| Q4 2023 | 36 | $2.35M |
| Q3 2023 | 34 | $2.40M |
| Q2 2023 | 32 | $3.47M |
| Q1 2023 | 33 | $10.2M |
| Q4 2022 | 34 | $9.93M |
| Q3 2022 | 33 | $12.0M |
| Q2 2022 | 35 | $8.79M |
| Q1 2022 | 28 | $8.83M |
| Q4 2021 | 30 | $8.68M |
| Q3 2021 | 24 | $4.42M |
| Q2 2021 | 5 | $5.43K |
| Q1 2021 | 5 | $8.68K |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding PharmaCyte Biotech, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 9 | $0 | 0.00% | −5,823−99.8% | Reduced |
| Huntington National Bank | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 139 | $0 | 0.00% | +11+8.6% | Added |
| Royal Bank of Canada | 98 | $0 | 0.00% | 00.0% | Unchanged |
| Blue Bell Private Wealth Management, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| TCI Wealth Advisors, Inc. | 3 | $0 | 0.00% | 00.0% | Unchanged |
| Carolina Wealth Advisors, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 1 | $0 | 0.00% | +1 | New |
| Heritage Financial Services, LLC | 67 | $0 | 0.00% | +67 | New |
| Federation des caisses Desjardins du Quebec | 7 | $16 | 0.00% | 00.0% | Unchanged |
| Anchor Investment Management, LLC | 27 | $60 | 0.00% | 00.0% | Unchanged |
| Kelly Financial Services LLC | 262 | $587 | 0.00% | 00.0% | Unchanged |
| Aspire Private Capital, LLC | 800 | $2.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,161 | $2.00K | 0.00% | +1,161 | New |
| Advisor Group Holdings, Inc. | 1,758 | $3.00K | 0.00% | +1,545+725.4% | Added |
| Bank of America Corp | 1,734 | $4.00K | 0.00% | +1,676+2,889.7% | Added |
| Morgan Stanley | 2,526 | $6.00K | 0.00% | −59,343−95.9% | Reduced |
| BlackRock Inc. | 8,881 | $20.0K | 0.00% | +8,881 | New |
| FNY Investment Advisers, LLC | 15,290 | $34.0K | 0.03% | −43,776−74.1% | Reduced |
| Millennium Management LLC | 17,519 | $40.0K | 0.00% | +17,519 | New |
| Schonfeld Strategic Advisors LLC | 26,200 | $59.0K | 0.00% | −100−0.4% | Reduced |
| Citadel Advisors LLC | 31,696 | $72.0K | 0.00% | +31,696 | New |
| Northern Trust Corp | 37,630 | $84.0K | 0.00% | +1,989+5.6% | Added |
| Simplex Trading, LLC | 54,927 | $123.0K | 0.00% | +54,927 | New |
| Price T Rowe Associates Inc | 62,000 | $140.0K | 0.00% | −16,100−20.6% | Reduced |
| State Street Corp | 62,600 | $141.0K | 0.00% | +25,000+66.5% | Added |
| Group One Trading, L.P. | 69,041 | $156.0K | 0.00% | +69,041 | New |
| Susquehanna International Group, LLP | 78,609 | $178.0K | 0.00% | +50,547+180.1% | Added |
| K2 Principal Fund, L.P. | 91,095 | $204.0K | 0.03% | +91,095 | New |
| Ayrton Capital LLC | 153,130 | $343.0K | 0.56% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 175,607 | $396.0K | 0.00% | +4,084+2.4% | Added |
| Equitec Proprietary Markets, LLC | 342,994 | $768.0K | 0.36% | +33,700+10.9% | Added |
| Vanguard Group Inc | 642,374 | $1.44M | 0.00% | +27,749+4.5% | Added |
| Shay Capital LLC | 982,698 | $2.20M | 1.14% | +38,032+4.0% | Added |
| Sabby Management, LLC | 1,061,411 | $2.38M | 4.41% | −214,057−16.8% | Reduced |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −2,723−100.0% | Sold out |
| Susquehanna Fundamental Investments, LLC | – | – | – | – | Not filed |